Skip to main content

Patterson Companies Value Stock - Dividend - Research Selection

Patterson

ISIN: US7033951036 , WKN: A0B6VB

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The company\'s Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery. This segment also develops and sells technology solutions, such as practice management software and e-commerce solutions. In addition, it offers a range of related services, including software and design, maintenance and repair, and equipment financing services. The company\'s Animal Health segment distributes animal health products, such as pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. This segment also offers a range of value-added services to animal health customers. Patterson Companies, Inc. serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul, Minnesota.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


PDCO Stock Gains on the News of Acquisition Deal With Patient Square

2024-12-16
Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

2024-12-15
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? Patterson Companies, Inc. (NASDAQ:PDCO) stock rocketed 35.60% after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital for approximately $4.1 billion. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) g

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

2024-12-12
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator

Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade)

2024-12-12
Financial writer discusses Patterson Companies' buyout, stock surge, and potential for higher bids, advising investors to hold shares. Read more here.

Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?

2024-12-11
Patterson Companies stock launched Wednesday after the dental outfit said it agreed to a $4.1 billion takeover deal from Patient Square.

Patterson Companies Surges 34% as Patient Square Capital Plans $4.1B Private Buyout

2024-12-11
Patient Square Capital acquires Patterson Companies for $4.1B, offering a 35.7% premium per share.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO

2024-12-11
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Monteverde & Associates PC , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services...

Patterson Companies Stock Soars Over 30% After $4.1 Billion Acquisition Deal

2024-12-11
Shareholders will receive $31.35 per share in cash, representing a significant premium over recent trading prices.

Patterson Companies Soars 35% on $4.1 Billion Buyout: A Game-Changer for Dental Stocks?

2024-12-11
Private equity giant Patient Square Capital bets big on Patterson, shaking up the struggling dental market.

Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal

2024-12-11
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar-day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day before Patterson announcing the evaluatio